Inebilizumab for Treatment of IgG4-Related Disease
Original Article
J.H. Stone, A. Khosroshahi, W. Zhang, E.D. Torre, K. Okazaki, Y. Tanaka, J.M. Löhr, N. Schleinitz, L. Dong, H. Umehara, M. Lanzillotta, Z.S. Wallace, M. Ebbo, G.J. Webster, F.M. Valle, M.K. Nayar, C.A. Perugino, V. Rebours, X. Dong, Y. Wu, Q. Li, N. Rampal, D. Cimbora, and E.L. Culver
N Engl J Med 2025;392:1168-1177
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.